Related Experiment Video
Updated: May 31, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
Idiopathic infantile hypercalcaemia in 5-month old girl
1Department of Paediatrics, Regional Hospital and Health Centre Česká Lípa, Česká Lípa, Czech Republic.
Insights
Idiopathic infantile hypercalcaemia (IIH) is a rare disorder causing high calcium levels in infants. Prompt treatment with low calcium diet, furosemide, and glucocorticoids can normalize calcium and improve symptoms.
Area of Science:
- Pediatric Endocrinology
- Mineral Metabolism Disorders
- Rare Diseases
Background:
- Idiopathic infantile hypercalcaemia (IIH) is a rare mineral metabolism disorder of unknown etiology.
- Characterized by hypercalcaemia, parathyroid hormone (PTH) suppression, hypotonia, failure to thrive, and nephrocalcinosis.
- Standard treatment involves dietary calcium restriction, glucocorticoids, and furosemide.
Observation:
- A 5-month-old female infant presented with failure to thrive, constipation, hypotonia, and dehydration.
- Serum calcium levels peaked at 4.25 mmol/l.
- Other potential causes of hypercalcaemia were systematically excluded.
Findings:
- Treatment with rehydration, a low-calcium diet, glucocorticoids, and furosemide led to normalization of serum calcium levels.
- Significant clinical improvement was observed within two weeks of treatment initiation.
- This case highlights the effectiveness of established treatments for IIH.
Implications:
- Early screening for hypercalcaemia in infants presenting with failure to thrive is crucial.
- Prompt initiation of corticosteroids and furosemide is recommended for suspected IIH.
- Further diagnostic evaluation is necessary to determine the underlying cause of hypercalcaemia.
Abstract:
Idiopathic infantile hypercalcaemia (IIH) is a mineral metabolism disorder of unknown origin. It is characterized by high levels of serum calcium resulting in parathyroid hormone (PTH) suppression, muscle hypotonia, thirst, anorexia, failure to thrive, psychomotor retardation, constipation, nephrocalcinosis. Treatment consists of low calcium diet, glucocorticoids, furosemide. We present a case of 5-month old girl with IIH, where total calcaemia peaked to 4.25 mmol/l. The leading symptoms were failure to thrive, constipation, muscle hypotonia, dehydration. Rehydration, low calcium diet, and application of glucocorticoids and furosemide resulted in a drop in calcaemia to normal values and an overall clinical improvement within two weeks. Williams-Beuren syndrome (WBS), benign familial hypocalciuric hypercalcaemia (FHH), neonatal severe primary hyperparathyroidism (NSHPT), Jansen's metaphyseal dysplasia, primary hyperparathyroidism, vitamin D intoxication, granulomatous diseases, thyroid disease, malignancy were all ruled out. In conclusion, infants with failure to thrive should have their serum levels of minerals, especially, calcium, checked. In case of hypercalcaemia, treatment with corticosteroids and furosemide should be initiated, together with further diagnostic steps in order to elucidate its origin.
Related Concept Videos
Inborn Errors of Metabolism
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Skeleton and Calcium Homeostasis
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Diabetic Ketoacidosis l: Introduction
